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Objectives. This study souaht to establish the validity, repro- 
ducibility and responsiveness of the Seattle Angina Question- 
naire, a 19.item self-administered questionnaire measuring five 
dimensions of coronary artery disease: physii 11 limitation, angi- 
nal stability, angina1 frequency, treatment satisfaction and dis- 
ease perception. 
Background. Assessing ihe functional status of patients is 
becoming increasingly important in both clinical research and 
quality assurance programs. No current functional status mea- 
sure quantifies all of the important domains alfected by coronary 
artery disease. 
MefAods. Cross-sectional or serial administration of the Seattle 
Angina Questionnaire was carried out in four groups of patients: 
70 undergoing exercise treadmill testing, 58 undergoing coronary 
angioplasty, 160 with initiahy stable coronary artery disease and 
an additional 84 with coronary artery disease. Evideuce of validity 
was sought by comparing the questionnaire’s five scales with the 
duration of exercise treadmill tests, physician diagnoses, oitro- 
Mortality reduction is a widely accepted criterion for demon- 
strating therapeutic efficacy in the treatment of coronary artcry 
di: ,dse. Yet, age-adjusted mortality rates have declined by 
5b 10 in the past X’ :/ears (1). As further therapeutic improvc- 
menis are realized, it will become increasingly difficult to 
compare the impact of alternattve treatments on mottalitv. 
Furthermore, as mortality declines, improving the quahty of 
life or functional status of survivors with coronary disease 
becomes increasingly important. 
Rather than focus on mortality, investigators often use 
physiologic measures, such as left ventricular ejection fraction, 
exercise treadmill duration or narrowing of coronary arteries, 
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glycerin refills and other validated instruments. Reproducibility 
and re:l%nsiveness were assessed by comparing serial responses 
over a &month interval. 
Rmd&s. All five scales correlated significantly with other mea- 
sures of diagnosis and patient function (r = 0.31 to 0.70, p 5 
0.001). Questionnaire responses of patients with stable coronary 
artery disease did not change over 3 months. The questionnaire 
was sensitive to both dramatic clinical change, as seen after 
successful coronary angioplasty, and to more subtle clinical 
change, as seen among outpatients with initially stable coronary 
artery disease. 
Conclusions. The Seattle Angina Questionnaire is a valid and 
reliable instrument that measures five clinically important dimeo- 
sions of health in patients with coronary artery disease. It is 
sensitive to clinical change and should be a valuable measure of 
outcome in cardiovascular research. 
(J Am Coli Cardiol 1995;25:333-41) 
as the primary outcome in clinica) trials (2-4). Although these 
surrogate end points do not obviate the need for evaluating 
martamy, they can be measured in all patients and can provide 
more powerful clinical trials with a given sample size. How- 
ever. a potentiai problem with the use of surrogate end points 
is that they may correlate poorly with both survival (5) and 
patients’ functional status (6-8). Directly monitoring patients’ 
ftmctional status not only increases the power of clinical trials 
but also examines an important goal of therapy. 
There is no universally accepted functional status measure 
for coronary disease (9). Most commonly used is the Canadian 
Cardiovascular Society classification, with which physicians 
rate patients’ functional status (10). The Specific Activity Scale 
and the Duke Activity Status Index predict physical Iimitation 
but lack specificity for coronary disease and do not address the 
full spectrum 0; limitation imposed by this condition (11,12). 
Several quality of life domains are important to patients 
with coronary disease. Like existing measures, an optimal 
measure should quantify the level of exertion that a patient 
routinely performs, especially because patients may alter their 
level of activity to minimize the frequency of their angina (13). 
Second, the frequency of angina should be measured because 
this is a critical marker of disease classifica! 3n (14). a prog- 
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Table 1. Studv Desiens 
Stcdy and Pts 
Validation studies 
Physical limitation 
Pts with CAD undergomg ETJ 
Angina1 stability 
I. Pts undergoing FTCA 
2. Pts with initially stable CAD 
Angina1 frequency 
Pts with initially stable CAD 
Treatment satisfaction 
Resident pts with self-reported CAD 
Disease perception 
Pts with initially stable CAD and P’XA 
Reproducibility study 
Pts with stable CAD 
Responsiveness studies 
1. Pts undergoing successful PICA 
2. Pts with initially stable CAD 
Reference Measure - 
E’ll duration, D.\SI, SAS, CCSC and SF-36 Pearson r coe8‘ 
1. Diagnosis of unstable angina 
2. Patient’s global perception of change 
No. of nitroglycerin refills 
ABIM PSQ 
SF-36 general health scale 
3-mo change in SAQ scores Paired t test, ICC 
1.3-mo change in SAQ scores 
2. 3-mo change in SAQ scores 
1. Paired t test 
2. Paired I test 
Analysis 
___-- 
I. Independent I test 
2. Pearson r coeff 
Pearson r coeff 
Pearson r coeff 
Pearson I coeff 
ABIM PSQ = American Board of Internal Medicine Patient Satisfaction Questionnaire; CAD = coronary artery 
disease; CCSC = Canadian Cardiovascular Society classification; coeff = coefficient; DASI = Duke Activity Status Index; 
ETT = exercise treadmill tc t; ICC = intraclass correlation coefficient; PTCA = percutaneous transluminal coronary 
angioplasty; Pts (pts) = patients; SAV = Seattle Angka Que;;tionnaire; SAS = SF&c Activity Scale; SF-36 = Short 
Form-36. 
nostic indicator (1517) and can signal the need for therapeu- 
tic change. Third, patients’ satisfaction with their treatment 
regimen should be quantified because it may alter therapeutic 
strategies and influence compliance (18). Finally, a functional 
status measure shouid assess patients’ perception of how their 
disease limits their quality of life. 
We developed a disease-specific functional status measure, 
the Seattle Angina Questionnaire, to quantify the physical and 
emotional effects of coronary artery disease. This instrument 
(Appendix) is a 19-item self-administered questionnaire result- 
ing in five scales that measure clinically important dimensions 
of coronary artery disease: physical limitation, angina1 stability, 
angina1 frequency, treatment satisfaction and disease percep- 
tion. 
To be useful, a functional status measure must be valid 
(measure what it intends to), reproducible and responsive to 
clinically important changes (19,20). This report evaluates a 
group of studies supporting the validity, reproducibility and 
responsiveness of the Seattle Angina Questionnaire. 
Methods 
Design of the Seattle Angiua Questionnaire. The physical 
limitation scale (question 1) is derived from the scales of 
Goldman et al. (11) and Feinstein and Well, (21) and mea- 
sures how daily activities are limited by symptoms of coronary 
disease. Specific activities were chosen to minimize ditferences 
among socioeconomic classes and gender. The angina1 sta- 
bility scale (question 2) assesses change in the frequency of 
angina at patients’ most strenuous level of activity. The angina1 
frequency scale (questions 3 and 4) is modified from the 
Angina Questionnaire of Peduzzi and Hultgren (22). The 
treatment satis:action scale (questions 5 to 8) quantifies pa- 
tients’ satisfaction with their current treatment, and the disease 
perception scale (questions 9 to 11) characterizes the burden 
of coronary artery disease on patients’ quality of life. 
The Seattle Angina Questionnaire is scored by assigning 
each response an ordinal value, beginning with 1 for the 
response that implies the lowest level of functioning, and 
summing across items within each of the five scales. Scale 
scores are then transformed to a 0 to 100 range by subtracting 
the lowest possible scale score, dividing by the rang? of the 
scale and multiplying by 100. Because each scale monitor5 a 
unique dimension of coronary artery disease, no summary 
score is generated. 
To improve response rate, the Seattle Angina Question- 
naire is brief and self-administered, requiring <5 min to 
complete. It was designed in a machine-readable format to 
permit fast, easy and inexpensive data entry. Furthermore, it 
can supplement a broader assssment of functional status, such 
as the Short Form-36 (23). 
Data collection. To assess questionnaire validity, reproduc- 
ibility and responsiveness, we studied four distinct patient 
groups. Table 1 outlines each study. All investigations were 
approved by the tiniversity of Washington Human Subjects 
Committee. 
Patients undergoing exercise treadmill test. All patients with 
coronary artery disease who had a symptom-limited treadmill 
test performed between November 1992 and February 1993 at 
a Veterans Affairs medical center and a university-affiliated 
outpatient clinic were studied. We considered coronary artery 
disease to be present if the patient had 1) a previous myocar- 
dial infarction; 2) a previous revascularization procedure or 
angiogram documenting coronary disease; or 3) characteristic 
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chest pain and abnormal treadmili test results at the time of 
the study. 
Each patient completed, in random order, three question- 
naires, including the Seattle Angina Questionnaire and the 
Duke Activity Status Index. Patients enrolled during the first 
6 weeks of the study completed the Specific Activity Scale 
administered by a trained interviewer. Subjects enrolled during 
the second half of the study completed the physical activity 
questions of the Short Form-36 instead of the Specific Activity 
Scale. The physician administering the treadmill test com- 
pleted a brief information sheet verifying the entry cri*eria and 
documenting the Canadian Cardiovascuidr Society Classifica- 
tion. 
Outpatients with self-reported coronav artery disease. The 
treatment satisfaction scale was validated among outpatients 
who reported that they had coronary artery disease in response 
to a smvey of all enrollees in an interna! medicine clinic who 
were under the care of third-year medical residents (n - 350). 
We mailed these patients the Seattle Angina Questionnaire 
and the American Board of Internal Medicine’s Patient Satis- 
faction Questionnaire, a valid measure of physicians’ human- 
istic qualities (24). 
Patients with initially stable coronary artery disease. The 
validity of the remaining three scales and the reproducibility of 
the entire Seattle Angina Questionnaire were studied in a 
cohort of patients with initially stable coronary artery disease 
identified from the Seattle Veterans Affairs Medical Center’s 
computerized data base. Enrollees in the General Internal 
Medicine Clinic were included if they met all of the following 
criteria: 1) a discharge diagnosis within the previous 5 years of 
coronary disease; 2) a current prescription for nitroglycerin; 
3) no change in antianginai medicines within the previous 9 
months; 4) no hospital admissions within 2 months; and 5) no 
diagnostic tests for evaluation of cardiac disease during the 2 
months preceding the study. 
Subjects were mailed the Seattle Angina Questionnaire and 
the Short Form-36. Three months later a similar packet was 
mailed that also contained a five-point global questionnaire 
inquiring whether angina1 symptoms had changed. Patients 
failing to respond were contacted by telephone to encourage 
completion, but questionnaires were not administered by 
telephone. Patients who required hospital admission or new 
antianginal medications during the study period were excluded 
trom the reproducibility analysis. 
Patients unde%oing percutaneous coronary angioplasty. To 
evaluate the responsiveness of the Seattle Angina Question- 
naire to clinical change, we administered it to patients under- 
going coronaI)r angioplasty, who we anticipated would experi- 
ence a significant improvement in their coronary artery 
disease. Patients were enrolled from the cardiac catheteriza- 
tion laboratories of a university medical center and a Vetercns 
Affairs medical center between September 1992 and January 
1993. Patients who were hypotensive, had undergone intuba- 
tion, did not speak English or were otherwise unable IO 
complete the questionnaires were excluded. The operating 
physician documented the indications for the procedure, du- 
ration of symptoms and presence CT absccc: cf r;;,st;bii 
angina. We defined unstable angina as either crescendo an- 
gina, new onset rest angina or angina requiring intravenous 
medications for pain control. 
Three months later. we mailed subjects the Seattle Angina 
Questionnaire, the Short Form-36 and a questionnaire inquir- 
ing about repeat invasive cardiac procedures. Nonrespondents 
were telephoned and encouraged to participate, but question- 
naires were not administered by telephone. Patients who 
underwent repeat catheterization were considered to have had 
unsuccessful initial revascularization and were excluded from 
the final analysis. 
Analyses. Validation of the physical limitation scale. We 
hypothesized that the physical limitation scale would be signif- 
icantly associated with patients’ exercise performance dura- 
tion. After adjusting for age, we correlated all administered 
instruments with the duration of treadmill test performance. 
Validation of the angina1 stabilig scale. Because this scale 
monitors change in angina1 symptoms, we hypothesized that 
patients with unstable angina would have a lower score than 
those with stable angina. Using a two-sample t test (two-tailed), 
we compared angina1 stability scores among angioplasty pa- 
tients with and without unstable angina. 
We also validated this scale in the cohort of patients with 
stable coronary artery disease, who, we expected, might expe- 
rience mild but detectable fluctuations in their angina1 severity. 
We correlated scores on the angina1 stability scale with pa- 
tients’ global rating of change as assessed in the 3-month 
follow-up question. 
Validation of the angina fiequenc) xale. We hypothesized 
that patients reporting a higher frequency of angina and 
nitroglycerin use on the Seattle Angiria Questionnaire would 
have more frequent refills of subiingJal nitroglycerin tablets. 
Because the pharmacy at the Seattle Veterans Affairs Medical 
Center is the primary source of medications for its patients, we 
examined its records for our sample of patients with stable 
coronary disease. Angina1 frequency scores were correlated 
with the number of nitroglycerin refills during the previous 
year. 
Validation of the treatment satisfaction scale. We validated 
the treatment satisfaction scale by correlating scores for this 
scale with scores for the American Board of Internal Medi- 
cine’s Patient Satisfaction Questionnaire among the outpa- 
tients who reported a diagnosis of coronary artery disease. 
Validation of the disease perception scale. We hypothesized 
that this scale would correlate significantly with the general 
health scale of the Short Form-36, a measure of personal 
evaluations of health, health outlook and resistance to illness. 
All patients who completed both the Seattle Angina Question- 
naire and the Short Form-36 served as the study group for this 
comparison. 
Reproducibility study. To evaluate reproducibility, we used 
paired t tests (two-tailed) and intraclass correlation coefficients 
to analyze the 3-month change in scores observed among 
patients with initially stable coronary artery disease. The 
intraclass correlation coefficient combines information from 
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Table 2. Correlations of Physical Limitation Scales With Exercise 
Treadmill Test Duration 
Physical Limitation 
Measure 
No. *If 
Pts 
Unadjusted r 
Coefficient 
(p value) 
&e-Adjusted r 
Coefficient 
(p valoe) 
SAQ physical score 70 
DASI score 70 
SF-36 physical score 26 
SAS score 44 
ccsc score 70 
Abbreviations a in Table 1. 
0.36(0.002) 0.42(0.001) 
0.36(0.002) 0.40 (0.001) 
0.29(0.16) 0.024(0.93) 
0.26 (0.09) 0.36(0.02) 
0.14(0.24) 0.21(0.11) 
the t test and the product moment correlation to describe the 
proportion of total variability attributable to between-person 
differences (19). Higher intraclass correlation coefficients 
(range 0 to 1) indicate greater reproducibility. 
Responsiveness study. Responsiveness to large clinical 
changes was tested using paired I tests (two-tailed) of baseline 
; nd follow-up scores among patients undergoing successful 
hngioplasty. 
Defining a smaller clinically relevant change in scores. Is 
addition to responsiveness in patients with major clinical 
improvement, we sought to define a smaller clinically impor- 
tant change in Seattle Angina Questionnaire scores (25). 
Knowing the change in score that reflects a meaningful change 
in clinical status facilitates score interpretation and sample size 
calculations in clinical trials. 
On the basis of patient responses to the global question 
inquiring about overall symptom change, we classified our 
sample of patients with initially stable coronary disease into 
three groups: those who rated thei; angina as worse, those who 
rated their angina as unchanged and those who felt their 
angina had improved. Using a paired t test (two-tailed), we 
compared the mean 3-month change in Seattle Angina Ques- 
tionnaire score? for each group. 
Results 
Validation studies. Physical limitation scale. Ail 70 pa- 
tients with coronary disease who underwent treadmill testing 
during the study period agreed to participate. The mean age 
was 61 years, and 95% were men. Adjusted for age, the Seattle 
Angina Questionnaire, the Duke Activity Status Index and the 
Specific Activity Scale were all significantly associated with 
total exercise duration (‘Fable 2) and with each other (r = 0.43 
to 0.84, p < 0.001). The age-adjusted correlation between 
exercise dnration and the Seattle Angina Questionnaire ex- 
ceeded that of all other measures. 
Angina1 stabil@ scale. On this scale, lower scores indicate 
more frequent angina, and higher scores less frequent angina, 
compared with the previous month. A score of 50 indicates no 
change in angina1 frequency at the patient’s most strenuous 
level of activity. 
We compared scores on the angina1 stability scale with the 
presence or absence of unstable angina at the time of corona5 
angioplasty a~irijiig patic i;ts who completed the questionnaire. 
The mean age of participants was 59 years, and 83% were men. 
Angina1 stability scores were significantly lower among patients 
with unstable angina than among those with stable angina (21.4 
vs. 39.8, p = 0.03). 
Among the cohort of patients with initis!ly stable angina, 
there was a significant correlation between the angina1 stability 
scale and patients’ perception of global change after 3 months. 
Of 160 questionnaires mailed to patients meeting our criteria 
for stable angina, 134 (84%) returned both the baseline and 
3-month questionnaires. The mean age of respondents was 68, 
and 98% were men, Angina1 stability scores correlated signif- 
icantly with patients’ global assessment of change (r = 0.7C, 
p < 0.0001). 
Anginal frequency scale. To establish the validity of the 
angina1 frequency scale, we studied the 134 patients who were 
selected for initially stable coronary artery disease. The corre- 
lation between the angina frequency score and l-year nitro- 
glycerin refills was 0.31 (p = 0.0006). 
Treatment satisfaction scale. There were I22 patients who 
reported a diagnosis of coronary artery disease, and 84 (69%) 
returned both the Seattle Angina Questionnaire and the 
American Board of Internal Medicine’s Patient Satisfaction 
Questionnaire. The mean age of respondents was 67 years, and 
95% were men. The two scales were highly correlated (r = 
0.67, p < 0.0001). 
Disease perception scale. Scores for the disease perception 
scale, obtained from the 134 patients with stable angina and 
the 58 patients undergoing angioplasty, were highly correlated 
with the general health perceptions scale of the Short Form-36 
(r = 0.60, p < 0.0001). 
Reproducibility study. Of 134 patients with initially stable 
coronary disease who returned both baseline and 3-month 
questionnaire; we excluded 17 who were either hospitalized or 
had received a new antianginal prescription during the study. 
The mean age of the remaining 117 patients was 69 years, and 
97% were men. 
No significant changes were observed among the Seattle 
Angina Questionnaire scales of patients with initially sta.ble 
coronary disease during the 3-month study period (Table 3). 
Except for the single-item angina1 stability scale, the intraciass 
correlation coefficients were quite high. 
Responsiveness study. Of 58 patients undergoing angio- 
plasty who compieted baseline queslionna’ires, 48 (83%) re- 
turned the 3-month follow-up questionnaires. There were no 
significant differences in age, gender, diagnosis of unstable 
angina, duration of angina or baseline questionnaire scores 
between patients who returned the follow-up questionnaires 
and those who did not. Three patients who underwent repeat 
catheterization were excluded. The final analyses were per- 
formed for 45 patients with a mean age of 60.2 years: 87% were 
men. 
Unlike the results in patients with initially stable coronary 
disease (Table 3), all scales except treatment satisfaction 
improved dramatically 3 months after successful angioplasty 
(Fig. 1). 
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Table 3. Mean 3-Month Change in Seattle Angina Questionnaire Scores Among Patients With Stable 
Coronary Artery Disease 
Baseline j-Month Intraclass 
Scale of the Seattle Angina Mean Mean Mean P Correlation 
Questionnaire Value Value Difference Value Coefficient 
--- ----_ ~-_ 
Physical limitation 50.2 51.3 1.1 0.48 0.83 
Angina stability 52.u 48.2 -3.8 0.1 0.24 
Angina frequency 61.5 66.5 -1 0.56 0.76 
Treatment satisfaction 78.1 77.1 -1 0.44 0.81 
Disease perception 56.7 56.2 -0.5 0.71 0.78 
Patients with stable coronary artery disease had no change in antianginal medications for 9 months before or during 
the study and had no hospital admissions or diagnostic cardiac tests 2 months before ur during the study. 
Defining a smaller clinically relevant change in scores. Of 
117 patients with initially stable angina, 28 reported worsening 
of their condition, 73 remained in stable condition, and 16 
reported improvement. All scales decreased in the group that 
reported worsening, remained unchanged in the patients with 
initially stable coronary disease and increased among the 
patients who reported an improvement (Fig. 2). The changes in 
ail but the treatment satisfaction scale were statistically signif- 
icant. A change in score of 10 points equaled or exceeded a 
change perceptible lo patients, and we interpreted this as a 
clinically important difference in scores. This contrasts with the 
improvements of 18 to 46 points seen among patients under- 
going angiopiasty (Fig. 2). 
Discussion 
The Seattle Angina Questionnaire. The Seattle Angina 
Questionnaire appears to be valid, reproducible and respon- 
sive. In support of its validity, we found pred;&$le and 
significant correlations between each scale and other, external 
measures of each domain. In support of its reproducibility, 
Figure 1. Mean 3-month change in Seattle Angina Ques- 
tionnaire scores among patients undergoing successful 
coronary angioplasty (n = 45). BTCA = percutaneous 
mean scores did not change after 3 months of observation 
among patients with stable coronary artery disease. In support 
of its responsiveness, mean scores improved dramatically after 
successful angiopiasty and to a lesser degree among patients 
experiencing smaller changes in the state of their coronary 
disease. 
There are two primary advantages of the Seattie Angina 
Questionnaire over existing measures. Despite its brevity, the 
self-administered Seattle Angina Questionnaire quantifies a 
broader spectrum of disease effects than the Canadian Cardio- 
vascular Society Classification, the Duke Activity Status Index 
or the Specific Activity Scale. Although these other instru- 
ments measure limitations in patients’ exertional capacity, the 
Seattle Angina Questionnaire not only captures this domain 
but also quantifies patients’ symptom frequency, symptom 
stability, satisfaction with treatment and quality of life. In 
addition, the Seattle Angina Questionnaire physicai limitation 
scale captures activity limitations specific to coronary artery 
disease, unlike the Specific Activity Scale, the Duke Activity 
Status !ndex and the Short Form-36, which also measure the 
effects of other comorbid conditions. 
Physical Limitation 
Anginai Stability 
Angina! Frequency (7 $-t-J p<~ <Ii 
transluminal coronary angioplasty; SAQ = Seattle Angina 
Questionnaire. 
Treatment Satisfaction 
Disease Percaption - 
0 20 40 50 80 100 
_.._ -.._.._ __ ._._ __-._ --.~ 
! !--.. Baseline Score 
, SAQ Scores 
Score 3 Months After PTCA 
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improved Patients (n=d6) 
Physical Limitetior 
Angina1 Stabilit) 
Angiral Frequent) 
Treatment Satisfaction 
Disease Perception 
Stable Patients (n=73) 
Physical Limita!ion 
Angina1 Stability 
Angina1 Frequency 
Treatment Satisfaction 
Disease Perception 
Deteriorated Patients (n=28) 
Physical Limitation 
Angina1 Stability 
Angina1 Frequency 
Treatment Satisfaction 
Disease Perception 
r- 
Figure 2. Mean 3-month change in Seattle Angina 
Questionnaire scores for subgroups of patients with 
initially stable coronary artery disease. Patients are 
grouped according to their perception of change in the 
;ty of their coronary artery disease. *p 5 0.05. **p 5 
-20 -10 0 10 20 30 
Mean 3 Month Change in Score 
This latter advantage is particularly important in patients 
with multiple medical problems. For example, if a patient with 
both rheumatoid arthritis and coronary disease were to have a 
flare-up of his or her arthritis without a change in the coronary 
disease, these other measures would detect a marked decrease 
in the patient’s activity. This change in activity could be 
mistakenly interpreted as a worsening of the patient’s coronary 
disease. !3y specifically teasing c;,t the limitations in activity 
caused by symptoms of angina, we hoped to create a more 
accurate measure of how a patient’s coronary disease influ- 
ences physical activity. The reliability and responsiveness of the 
Seattle Angina Questionnaire suggest that we have had some 
success with our approach, 
A common criticism of quality of life measures in clinical 
research is that the data are “soft.” Researchers often consider 
that information provided by patients is less reliable than that 
obtained by clinicians or physiologic tests. However, some 
researchers have argued that ihe essence of “hardness” is 
consistency or reproducibility (27). It is noteworthy that the 
intraclass correlation coefficient of serial exercise treadmill 
tests, administered 1 day apart, is 0.70 (28) whereas that of our 
physical limitation scale, administered 3 months apart, is 
substantially higher at 0.83. 
Study limitations. Validating the Seattle Angina Qnestion- 
naire was complicated by the absence of reference standards 
for functional status domains. Although we recognize the 
limitations of our comparison standards, we believe that these 
were the best options available. Not surprisingly, corre!ations 
with other questionnaires were higher than those of exercise 
duration or nitroglycerin refills. The lowest correlations were 
seen in validating the angina1 frequency scale. Medication 
refills are an imperfect measure of angina1 frequency because 
patients may not consume all of the medication received, may 
not use nitroglycerin with each episode of angina and may 
obtain prescriptions outside the Veterans Affairs system. Nev- 
ertheless, this approach has been demonstrated to be a valid 
method of estimating medication use, and our correlations 
approximate those observed behveen antihypertensive drug 
refills and diastolic blood pressure reduction or anticonvulsant 
agent refills and plasma drug levels (25). 
The predominance of elderiy men in our study, hugely 
reflecting the clientele of a Veterans Atfairs medical center, 
may limit the generalizability of our findings. However, the 
high prevalence of comorbid conditions among this population 
attests to the specificity of the Seattle Angina Questionnaire 
in monitoring the unique functional limitations of coronary 
disease. Additional studies should be performed in women 
and other socioeconomic groups to verify our findings. An 
additional caveat of our questionnaire is the focus of several 
scales on angina1 symptoms. Although patients with atypical 
symptoms or silent ischemia may have difficulty answering 
these questions, none of our studies restricted entry to only 
those with classical symptoms. Nevertheless, the Seattle 
Angina Questionnaire may have limited use in these 
populations. 
The incomplete response rate of study subjects to our 
mailed questionnaires may represent a final potential limita- 
tion of our study. Although we detected no baseline differences 
between those who responded to follow-up questicnnaires and 
those who did not, WC cannot exclude a potential bias in our 
results from the failure of all study participants to return 
follow-up questionnaires. 
Conclusions. The use of functional status instruments as 
an outcome in clinical research is a promising technique. 
Indeed, a major thrust of current efforts to characterize 
treatment outcome is toward measures that are highly relevant 
to both patienis and society. In general, this includes direct 
measures of health-related quality of life. Reliable and valid 
measures, such as the Seattle Angina Questionnaire, can serve 
an important role as sensitive and clinically meaningful out- 
come measures in cardiovascular research. 
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The Seattle Angina Questionnaire 
1. The following is a list of activities that people often do during the week. Although for 
some people with several medical problems it is dilhcult to determine what it is that limits 
them, please go over the activities listed below and indicate how much limitation you have 
had due to chest pain, chest tightness, or angina over the Dast 4 weeks. 
- Place an x in one box on each line. 
Limited, 
or did 
Activity Severely Moderately Somewhat *A Little Not not do 
Limited Limited Limited Limited Limited for other 
reasons .- 
Dressing yourself 0 cl 0 0 Cl a 
Walking indoors on 0 0 0 0 0 0 
level ground 
Showering 0 0 0 0 a 0 
Climbiilg a hill or a 
flight of stairs without 
stopping 
0 0 0 0 0 0 
CIderring, 
vacuumin~ or carrying 
groceries 
0 0 0 0 0 0 
Walking more than a 0 0 0 0 0 a 
block at a brisk pace 
Running or jogging 0 0 0 0 0 0 
Lifting or moving 
heavy objects (e.g. 
furniture, children) 
0 0 0 0 0 0 
Participating in 
strenuous sports (e.g. 
swimming, tennis) 
0 0 0 0 0 0 
2. @Dar& with 4 weeks ago, how often do you have chest pain, chest tightness, or 
angina when doing your most strenuous level of activity? 
I have had chest pain, chest tightness, or angina... 
Much more Slightly more About the Slightly less Much less 
0Ren often same often often 
0 0 0 0 0 
3. Over the past 4 weeks, on average, how many times have you had chest pain, chest 
tightness, or angina? 
I get chest pain, chest tightness, or angina.. 
4 or more 
times per 
dav 
l-3 times 3 or more times 1-2 times Less than None over 
per day per week but per week once a the past 4 
not every day week weeks 
d 0 q -- a 0 0 
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4. Over the past 4 weeks, on average, how many times have you had to take nitros 
(nitroglycerin tablets) for your chest pain, chest tigltness, or angina? 
I tak,: nitros... 
4 or more 1-3 times 3 or more times l-2 times Less than None over 
times per per day per week but per week once a the past 4 
day not every day week weeks 
Cl 0 0 cl 0 cl 
5. How bothersome is it for you to take your pills for chest pain, chest tightness or 
angina as prescribed? 
Very Moderately Somewhat A little Not My doctor 
bothersome bothersome bothersome bothersome bothersome has not 
at all prescribed 
pills 
0 0 0 Q 0 Q 
0. How satisfied are you that everything possioie is being done to treat yoiir chest pain, 
chest tightness, or angina? 
Not satisfied Mostly Somewhat Mostly w&JY 
at all dissatisfied satisfied satisfied satisfied 
cl 0 Cl 0 0 
7. How satisfied are you with the explanations your doctor has given you about your 
chest pain, chest tightness, or angina? 
Not satisfied Mostly Somewhat Mostly WJY 
at all dissatisfied satisfied satisfied satisfied 
0 0 0 0 0 
8. Overall, how satisfied tie you with the ctirren; treatment of yola chest pain, chest 
tightness, or angina‘? 
Not satisfied Mostly Somewhat Mostly fit$lY 
at all dissatisfied satisfied satisfied satisfied 
cl cl Q 0 0 
9. Over the past 4 weeks, how much has your cheat pain, chest tightness, or angina 
interfered with your enjoyment of We? 
It has severely It has It has slightly It has barely It has not 
limited my moderately limited my limited my limited my 
enjoyment of limited my enjoyment of enjqment of enjoyment of 
life enjoyment of lie life life life 
0 0 a 0 0 
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10. If you hd to spend the rest of your lifii with your chest pain, chest tightness, or 
angina the way it is right now, how would you reel about this? 
Not satisfied Mostly Somewhat Mostly H&W 
at all dissatistied satisfied satisfied satisfied 
e e 0 a a 
i i . How often do you worry that you may have a heart attack or die suddenly? 
I can’t stop I often think I occasioaally I rarely think I never think 
worrying or won-y worry about it or wony or worry 
about it about it about it about it 
cl R cl Ll cl 
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